ArticleCancer medicine2026

Predicting Poor Efficacy of Cabozantinib in Advanced Renal Cell Carcinoma by Exploratory Metabolic Pathway Analysis and In Vitro Verification.

Takanari Sakai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.